Transcription Factor |
Target ORF/Genes |
References |
Evidence Code |
Evidence Experiment |
Association Type |
Strain |
Environmental Group |
Environmental Condition |
Log2FC |
|
Ixr1p
|
YHR096C
|
PubMed
Lee TI et al., Science (New York, N.Y.), 2002 Oct 25;298(5594):799-804Lee TI et al., Science (New York, N.Y.), 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
Unstressed log-phase growth (control) |
YPD medium; mid-log phase |
N/A |
PubMed
Workman CT et al., Science (New York, N.Y.), 2006 May 19;312(5776):1054-9Workman CT et al., Science (New York, N.Y.), 2006 May 19;312(5776):1054-9 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
N/A |
N/A |
PubMed
Reimand J et al., Nucleic acids research, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic acids research, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF Deletion |
Positive |
BY4741; S288C; R1158 |
Unstressed log-phase growth (control) |
Standard YPD conditions Dataset ewxtracted from The Longhorn Array Database (LAD). Transcription factor gene deletion. |
0.35588538937037 |
PubMed
Vizoso-Vázquez A et al., Applied microbiology and biotechnology, 2012 Apr;94(1):173-84Vizoso-Vázquez A et al., Applied microbiology and biotechnology, 2012 Apr;94(1):173-84 |
Indirect |
Microarray analysis - wt vs TF mutant |
Negative |
S288c |
Oxygen availability |
Hypoxia |
N/A |
PubMed
Krakowiak J et al., eLife, 2018 Feb 2;7():Krakowiak J et al., eLife, 2018 Feb 2;7(): |
Indirect |
Microarray analysis - WT vs TF Deletion |
Positive |
W303a |
Unstressed log-phase growth (control) |
Grown overnight in complete SD medium with specific amino acid supplements and 2% glucose, then diluted to OD600 0.4 in fresh medium and cultured at 30 °C with shaking until mid-log phase (OD600 0.6). Transcription factor gene deletion. |
0.65357667 |
| Indirect |
Microarray analysis - WT vs TF Deletion |
Positive |
W303a |
Stress |
Grown overnight in complete SD medium with specific amino acid supplements and 2% glucose, then diluted to OD600 0.4 in fresh medium and cultured at 30 °C with shaking until mid-log phase (OD600 0.6). Cisplatin treatment (600 μM in DMSO), incubated for 4 hours at 30 °C in the dark with agitation. Transcription factor gene deletion. |
0.55235 |